Literature DB >> 34296296

The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).

Gu Yang1, Yanjiao Wu2, Rongxue Wan3, Hongxun Sang4, Huan Liu5, Wenhua Huang1.   

Abstract

Osteosarcoma (OS) is the most common primary bone tumor worldwide. OS exhibits a range of aggressive behaviors, including early metastasis potential, rapid progression, poor clinical prognosis and insensitivity to chemoradiotherapy. Non‑coding RNAs are transcripts that do not encode proteins. A significant number of studies published on OS have been focused on the aberrant expression of non‑coding RNAs and their involvement in tumor initiation and progression. It has been confirmed that non‑coding RNAs exert their regulatory functions at both the transcriptional and post‑transcriptional level, which leads to tumor initiation or progression in OS. According to present knowledge, this review provides a state‑of‑the‑art overview of the functions and mechanisms of microRNAs, long non‑coding RNAs and circular RNAs in terms of their involvement with OS. The review also covers their potential clinical application in the diagnosis, prognosis and treatment of OS. It is hoped that the information presented in this review on the involvement of non‑coding RNAs in OS will lead to a more comprehensive understanding of OS and provide a useful perspective on the potential diagnostic and therapeutic applications of non‑coding RNAs for patients with OS.

Entities:  

Keywords:  circular RNAs; long non‑coding RNAs; microRNAs; non‑coding RNAs; osteosarcoma

Mesh:

Substances:

Year:  2021        PMID: 34296296     DOI: 10.3892/ijo.2021.5249

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

Review 1.  The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets.

Authors:  Jinxin Liu; Guanning Shang
Journal:  Front Cell Dev Biol       Date:  2022-02-16

2.  Silencing circOMA1 Inhibits Osteosarcoma Progression by Sponging miR-1294 to Regulate c-Myc Expression.

Authors:  Yubo Shi; Yunyun Tian; Xiangran Sun; Yonglong Qiu; Yingchun Zhao
Journal:  Front Oncol       Date:  2022-04-13       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.